Mode
Text Size
Log in / Sign up
N/A N=20 Treatment

GameSquad for Adults With Down Syndrome

Down Syndrome · Physical Inactivity

Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: Minutes of Gameplay Per Week — 100.32 minutes/week

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Ring-Fit Adventure Group (Behavioral)
Age
Adult · 18+ yrs
Sex
All
Sponsor
University of Kansas Medical Center
Primary completion
Jun 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Minutes of Gameplay Per Week
100.32
PRIMARY
Retention
19
PRIMARY
Attendance
92.45
SECONDARY
6-minute Walk Test
401.13; 399.26
SECONDARY
Leg Strength
199.67; 246.50
SECONDARY
Hand Grip Strength
20.36; 19.58; 20.15; 19.72
SECONDARY
Timed Up and Go
6.00; 6.14
SECONDARY
Balance
48.86; 47.44; 47.63; 49.14; 76.03; 80.75
SECONDARY
Adverse Events
SECONDARY
Qualitative Interview Data

Summary

The investigators are assessing acceptability, appropriateness, and feasibility of the adapted GameSquad-DS intervention using validated scales alongside qualitative data among young adults with Down Syndrome. Specifically, the investigators will assess mins/wk of Ring-Fit Adventure played, attendance at 30 min. virtual health coaching sessions, semi-structured interviews, participant retention, and intervention safety measured as number of adverse events.

Eligibility Criteria

Inclusion Criteria

  • Young adults (18-30 yrs.).
  • Diagnosis of DS.
  • Sufficient functional ability to understand directions, communicate preferences, wants, and needs through spoken language.
  • Living at home with a parent/guardian or in a supported living environment with a parent/caregiver who agrees to serve as a study partner.

Exclusion Criteria

  • Unable to participate in MVPA.
  • Serious medical risk, e.g., cancer, recent heart attack, stroke, angioplasty as determined by their primary care provider (PCP).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05473247). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search